More Openness on Lab Animals

Dozens of U.K. research groups agree to publicly disclose more information about their animal subjects.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JANET STEPHENSPharmaceutical behemoth Bayer used 142,084 animals—primarily mice and rats—for research in 2013. Posting these data online, the firm illustrates where public disclosure is headed in the U.K. in terms of how—and how many—animal subjects are employed in the service of science. Dozens of research organizations in the U.K. this week (May 14) signed an agreement to more openly share information on animal studies.

“For many years, the only ‘information’ or images that the public could access about animal research were provided by organisations opposed to the use of animals in scientific progress,” Wendy Jarrett, the chief executive of Understanding Animal Research and the chair of the working group that developed the Concordat on Openness on Animal Research in the U.K., said in a statement. Signatories of the Concordat, including professional societies, biomedical companies, and universities, agreed to disclose when, how, and why they use animals in research and to be more open with the public and the media about animal research.

Animal rights organizations were not appeased by the effort to create more transparency. Wendy Higgins, the communications director of the Humane Society International, told the BBC: “This ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies